胸腔內科

2022

Distinct B and NKT cell responses shape the delayed response to ChAdOx1 nCoV-19 vaccine in end-stage renal disease

Putri, D. U., Lin, C. F., Hung, C. S., Huang, C. K., Ou, T. Y., Lai, C. Y., Tseng, P. C., Cheng, C. Y. & Lee, C. H., 6月 2022, 於: Journal of Infection. 84, 6, p. e122-e125

研究成果: 雜誌貢獻 › 快報 › 同行評審

開啟存取

Nosocomial septicemia in COVID-19 nosocomial K. pneumoniae, A. baumannii, and Elizabethkingia meningoseptica septicemia in a patient of COVID-19

Ong, J. Y., Wang, C-H., Tsai, Y. S., Chen, F-L., Lee, C. & Ou, T. Y., 7月 2022, 於: Journal of Infection. 85, 1, p. 90-122 33 p.

研究成果: 雜誌貢獻 › 快報 › 同行評審

開啟存取

SARS-CoV2 antibody response after a third dose of heterologous ChAdOx1 nCoV-19 and Moderna vaccine in chronic dialysis patients

Cheng, C. Y., Hsiao, S. H., Fang, T. C., Lin, Y. C., Wang, J. C. C., Hung, C. S., Chen, T. H. & Sue, Y. M., 6月 2022, 於: Journal of Infection. 84, 6, p. e98-e100

研究成果: 雜誌貢獻 › 快報 › 同行評審

開啟存取

1 引文斯高帕斯（Scopus）

2021

Acute generalized exanthematous pustulosis induced by atezolizumab in a patient with lung adenocarcinoma

Chang, H. C., Ko, P. H., Chang, Y. S. & Chou, P. C., 9月 2021, 於: Lung Cancer. 159, p. 175-176 2 p.

研究成果: 雜誌貢獻 › 快報 › 同行評審

3 引文斯高帕斯（Scopus）

Higher alveolar deposition of particulate matter in emphysematous lobes of COPD

Tung, N. T., Ho, S. C., Lu, Y. H., Chen, T. T., Lee, K. Y., Chen, K. Y., Wu, C. D., Chung, K. F., Kuo, H. P., Thao, H. N. X., Dung, H. B., Thuy, T. P. C., Wu, S. M., Kou, H. Y., Lee, Y. L. & Chuang, H. C., 2021, 於: ERJ Open Research. 7, 3, 00324-2021.

研究成果: 雜誌貢獻 › 快報 › 同行評審

開啟存取

4 引文斯高帕斯（Scopus）

N−3 fatty acid supplementation in asthma management: A systematic review and meta-analysis

Wang, Y. H., Huang, S. Y., Kuo, H. P., Fan, H. Y., Moreira, A., Papamichael, M. M. & Chen, Y. C., 11月 2021, 於: Allergy: European Journal of Allergy and Clinical Immunology. 76, 11, p. 3042-3046 5 p.

研究成果: 雜誌貢獻 › 快報 › 同行評審

Particulate matter and SARS-CoV-2: A possible model of COVID-19 transmission

Tung, N. T., Cheng, P. C., Chi, K. H., Hsiao, T. C., Jones, T., BéruBé, K., Ho, K. F. & Chuang, H. C., 1月 1 2021, 於: Science of the Total Environment. 750, 141532.

研究成果: 雜誌貢獻 › 快報 › 同行評審

64 引文斯高帕斯（Scopus）

2020

COVID-19: An aerosol’s point of view from expiration to transmission to viral-mechanism

Hsiao, T. C., Chuang, H. C., Griffith, S. M., Chen, S. J. & Young, L. H., 5月 2020, 於: Aerosol and Air Quality Research. 20, 5, p. 905-910 6 p.

研究成果: 雜誌貢獻 › 快報 › 同行評審

開啟存取

38 引文斯高帕斯（Scopus）

New diseases and old threats: Lessons from tuberculosis for the COVID-19 response

Dara, M., Sotgiu, G., Reichler, Chiang, C. Y., Chee, C. B. E. & Migliori, G. B., 5月 1 2020, 於: International Journal of Tuberculosis and Lung Disease. 24, 5, p. 544-545 2 p.

研究成果: 雜誌貢獻 › 快報 › 同行評審

41 引文斯高帕斯（Scopus）

Tackling the threat of COVID-19 in Africa: An urgent need for practical planning

Chiang, C. Y. & Sony, A. E., 5月 1 2020, 於: International Journal of Tuberculosis and Lung Disease. 24, 5, p. 541-542 2 p.

研究成果: 雜誌貢獻 › 快報 › 同行評審

20 引文斯高帕斯（Scopus）

The impact of COVID-19 and the restoration of tuberculosis services in the Western Pacific Region

Chiang, C. Y., Islam, T., Xu, C., Chinnayah, T., Garfin, A. M. C., Rahevar, K. & Raviglione, M., 2020, 於: European Respiratory Journal. 56, 4, 2003054.

研究成果: 雜誌貢獻 › 快報 › 同行評審

開啟存取

23 引文斯高帕斯（Scopus）

The impact of smoking on TB treatment outcomes includes recurrent TB

Chiang, C. Y. & Bam, T. S., 11月 1 2020, 於: International Journal of Tuberculosis and Lung Disease. 24, 11, p. 1224-1225 2 p.

研究成果: 雜誌貢獻 › 快報 › 同行評審

3 引文斯高帕斯（Scopus）

2019

Prognostic factors and first-line treatment modalities in nonagenarian patients with lung cancer

Hsu, C. C., Huang, Y. T., Tseng, Y. H., Luo, Y. H. & Chen, Y. M., 5月 1 2019, 於: Journal of Geriatric Oncology. 10, 3, p. 439-441 3 p.

研究成果: 雜誌貢獻 › 快報 › 同行評審

1 引文斯高帕斯（Scopus）

Tolerability of rifapentine-based regimens in latent tuberculosis infection treatment in the elderly

Chan, P. C., Lee, P. H., Lu, M. J., Huang, Y. C., Feng, T. Y., Chen, W. W., Lee, C. C., Huang, Y. F. & Chiang, C. Y., 3月 1 2019, 於: The European respiratory journal. 53, 3, 1802396.

研究成果: 雜誌貢獻 › 快報 › 同行評審

開啟存取

3 引文斯高帕斯（Scopus）

2017

Gefitinib or erlotinib for previously treated lung adenocarcinoma: Which is superior?

Chang, C. H., Lee, C. H. & Wang, J. Y., 4月 20 2017, 於: Journal of Clinical Oncology. 35, 12, p. 1374 1 p.

研究成果: 雜誌貢獻 › 快報 › 同行評審

4 引文斯高帕斯（Scopus）

Shortened multidrug-resistant tuberculosis regimens overcome low-level fluoroquinolone resistance

Van Deun, A. & Chiang, C. Y., 6月 1 2017, 於: European Respiratory Journal. 49, 6, 1700223.

研究成果: 雜誌貢獻 › 快報 › 同行評審

17 引文斯高帕斯（Scopus）

Tuberculosis contact investigation in an intermediate burden setting: implications from a large tuberculosis contact cohort in Taiwan

Lee, M. R., Ho, C. M., Lee, C. H., Lee, M. C., Chang, L. Y., Yu, K. L., Ko, J. C., Wang, J. Y., Wang, J. T. & Lee, L. N., 8月 1 2017, 於: The European respiratory journal. 50, 2, 1700851.

研究成果: 雜誌貢獻 › 快報 › 同行評審

13 引文斯高帕斯（Scopus）

2015

An integrated MDR-TB management programme results in favourable outcomes in northern Taiwan

Yu, M. C., Chen, H. Y., Chien, S. H. & Jou, R., 1月 1 2015, 於: European Respiratory Journal. 45, 1, p. 272-275 4 p.

研究成果: 雜誌貢獻 › 快報 › 同行評審

8 引文斯高帕斯（Scopus）

Coinfection of Pneumocystis jiroveci pneumonia and pulmonary tuberculosis in a non-HIV-infected patient

Suk, C. W., Bai, K-J., Yu, M-C. & Hu, T. Y., 12月 1 2015, 於: Journal of Microbiology, Immunology and Infection. 48, 6, p. 711-712 2 p.

研究成果: 雜誌貢獻 › 快報 › 同行評審

3 引文斯高帕斯（Scopus）

2009

Weekly cetuximab and gemcitabine plus cisplatin as salvage therapy for unresectable non-small cell lung cancer

Tai, C. J., Hsu, C. H., Wang, F. J., Chau, W. K., Chung, C. L. & Hsieh, C. C., 11月 2009, 於: Onkologie. 32, 11, p. 685-686 2 p.

研究成果: 雜誌貢獻 › 快報 › 同行評審

研究成果

搜尋結果